Get started Log in

ORX — Orexo AB Share News

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Market Cap
SEK206.18m
Enterprise Value
-SEK60.82m
Revenue
SEK26.00m

Brief: Orexo Q1 EPS at SEK -1.86
27/04/2023 07:14
Brief: Orexo AB It Was Resolved, In Accordance With Board Of Directors' Proposal, That There Shall Be No Dividend For 2022
18/04/2023 18:34
Brief: Orexo Announced New Timeline For OX124
03/04/2023 07:39
Brief: Orexo Postpones Publication Of The Annual Report
15/03/2023 18:14
Brief: Orexo Submits New Drug Application To FDA For OX124, High-Dose Rescue Medication For Opioid Overdose
03/02/2023 07:04
Brief: Orexo AB Q4 Revenues Rise To SEK 156.1 Million
26/01/2023 07:06
Brief: Orexo Q4 Revenue Falls Short of Estimates
26/01/2023 07:01
Brief: Orexo Initiates Feasibility Studies Of Amorphox
09/01/2023 07:06
Brief: Orexo Q3 EBITDA Loss SEK Narrows To 32.4 Million
03/11/2022 07:16
Brief: Orexo Announces Positive Data From Phase 1 Clinical Study For OX640
11/10/2022 07:05
Brief: Orexo Partner Trinity Health To Offer Vorvida, Deprexis To Patients
07/09/2022 15:59
Brief: Orexo's Adrenaline Product Ox640 Receives First European Patent
01/09/2022 07:06
Brief: Orexo Q2 EBITDA Loss Widens To SEK 32.5 Mln
14/07/2022 07:08
Brief: Orexo's Nasal Adrenaline Rescue Medication OX640 Enters Clinical Development
05/07/2022 07:04
Brief: Orexo Q1 EBITDA Swinga To Profit Of SEK 2.8 Mln
28/04/2022 07:20
Brief: Orexo Appoints Fredrik Järrsten As New CFO
11/03/2022 07:05
Brief: Orexo's Zubsolv Added To NY State Medicaid Mat Preferred Drug List
24/02/2022 07:23
Brief: Orexo Develops A Nasal Adrenaline Medication
02/12/2021 07:03
Brief: Orexo Announces Positive Results From Pivotal Trial For Its Leading Pharmaceutical Pipeline Asset OX124
16/11/2021 07:05
Brief: Orexo Q3 EBITDA Loss At SEK 47.4 Mln
03/11/2021 07:23